Home | | Search | BG-Portal | BG-Infoline | English
Latest news and trends | Prevention committees | Development of BG rules and regulations | Cooperative alliances | BGZ information service | About us |
     
 
Prevention committees
linie_nav
Industry-specific expert committees
linie_nav
Coordinating Groups
•  Coordinating Committee on Industrial Safety (KOBS)
•  Coordinating Group
on Hazardous Substances (KOGAS)
•  Coordinating
Group on Biological Agents (KOBAS)
•  Coordinating Committee
on Workplaces
(KOSTÄTT)
linie_nav

Coordinating Group on Biological Agents (KOBAS)
The "Koordinierungskreis für Biologische Arbeitsstoffe" (Coordinating Group on Biological Agents, KOBAS) is one of the statutory accident insurance institutions’ prevention committees. It is concerned with occupational safety and health (OSH) issues related to biological agents, i.e.:
  • microorganisms such as bacteria, viruses and fungi,
  • cell cultures and
  • human pathogenic endoparasites,
which can provoke infections or sensitising or toxic effects in humans. Agents such as the BSE pathogen also count as biological workplace agents.

KOBAS is intended to help the accident insurance institutions form an opinion on how to interpret and evolve the Biostoffverordung (Ordinance on Biological Agents) and the body of regulations which supplement it. KOBAS also supports the collaboration between Germanys’ Federal Ministry of Labour and Social Affairs and the prevention committees of the statutory accident insurance institutions.

KOBAS is based at the "Hauptverband der gewerblichen Berufsgenossenschaften" (German Federation of Institutions for Statutory Accident Insurance and Prevention, HVBG). It is supervised and managed by the "Berufsgenossenschaftliche Zentrale für Sicherheit und Gesundheit" (BG Central Office for Health and Safety at Work, BGZ) and consists of: KOBAS’ tasks are outlined below (only available in german).


KOBAS – an important interface

KOBAS provides support for cooperation between the prevention committees and the ABAS, which advises the Federal Ministry of Labour and Social Affairs. It develops a harmonised opinion on what protection measures the accident insurance institutions feel should be taken to tackle current OSH problems involving biological workplace agents. The standpoint established within KOBAS on specific OSH issues in the field of biological agents is presented to external parties, particularly the ABAS, where it serves as the statutory accident insurance institutions' contribution to pertinent debate. However, KOBAS also sets up its own working groups. One task force, for instance, collected examples of user instructions drawn up in accordance with the Ordinance on Biological Agents and published them, along with information on how to write user instructions, in a BG information sheet entitled "Betriebsanweisungen nach der Biostoffverordnung" (User instructions as specified in the Ordinance on Biological Agents, BGI 853).


Overview of rules, regulations and information sheets relevant to the area of protection against biological agents

Latest news

"Respiratory protection against airborne infectious diseases"

Influenza

In view of the continuing and recurring incidence of avian flu in the human population of Asia as well as German and international efforts to put influenza pandemic plans in place, a KOBAS task force has investigated which respiratory protection devices can be recommended to workers in order to protect them against influenza.

The task force consists of experts from the following bodies: the BG Expert Committee on Personal Protective Equipment, BG Expert Committee on Health and Welfare Services, BGIA, BGZ (which heads up the force), the "Bundesverband der Unfallkassen" (Central Federation of Public-Sector Accident Insurers, BUK), Germany's federal states, the BAuA and the Robert Koch Institute.

Having inspected and discussed the available data and taking into account a series of experiments which the BGIA recently conducted on face-masks in accordance with the test specification in DIN EN 149 "Respiratory protective devices – Filtering half masks to protect against particles – Requirements, testing, marking" (2001), the task force feels it would make sense to use a differentiated procedure to decide which respiratory protection devices should be worn to provide protection against influenza. The procedure is based on a qualitative risk estimation in conjunction with the total inward leakage rates specified in DIN EN 149 and results in the following categories:
  • persons who come into contact with suspected sufferers of influenza or engage in certain, specified activities are recommended to wear an FFP1 mask or a face-mask which meets the requirements set out for FFP1 masks in DIN EN 149 (total inward leakage no higher than approx. 22%; arithmetic mean for 10 test persons x 5 exercises);
  • persons who treat and care for patients with influenza are recommended to wear an FFP2 mask (total inward leakage approx. 8%);
  • persons who perform actions on patients which can provoke coughing (e.g. bronchoscopies, intubation and suction) are recommended to wear an FFP3 mask (total inward leakage approx. 2%); and
  • persons suspected of suffering from influenza ⁄ influenza patients shall be offered a face-mask, provided their state of health so permits.
This table gives a brief overview of the recommendations drawn up by the KOBAS task force (PDF file: 53 KB) (only available in german). Within the framework of what is known as the "cooperation model" (described in the Bundesarbeitsblatt (Federal Labour Gazette), Issue 5, 2001, page 61), the ABAS Committee on Biological Agents, which is based at the Federal Ministry of Labour and Social Affairs, examined the recommendations and incorporated them into its body of technical rules on 27 April 2005 as Resolution 609, "Arbeitsschutz beim Auftreten von Influenza unter besonderer Berücksichtigung des Atemschutzes" (Occupational safety and health in cases of influenza outbreaks, focusing particularly on respiratory protection). Resolution 609 can be downloaded in full here (PDF file 79 KB) (only available in german).


Prevention of needlestick injuries

In October 2003, the BG Expert Committee on Health and Welfare Services and the Committee on Biological Agents (ABAS) at the then Federal Ministry of Economics and Labour published BGR/TRBA 250, "Biologische Arbeitsstoffe im Gesundheitswesen und der Wohlfahrtspflege" (Biological agents in healthcare and welfare facilities), which supplements the Ordinance on Biological Agents. The aims of BGR/TRBA 250 include prevention of needlestick injuries and cuts suffered by medical and care staff. The risk of infection involved in such injuries makes for a not inconsiderable health risk for such staff. In particular, infections with hepatitis B or C or HIV can cause severe and sometimes chronic illness in the persons affected, which in turn causes high costs.

In 2005, the BG for the health and welfare services, the BGZ, BGIA and Federal Ministry of Labour and Social Affairs revisited the problem of needlestick injuries. They commissioned a metaanalysis entitled "Effectiveness of measures to prevent needlestick injuries among employees in health professions", the results of which will be described in an HVBG report.

Findings from the study have also played a part in the consultations concerning the updating of TRBA 250. On 17 May 2006, the ABAS decided to revise Section 4.2.4. As a result, injury-proof instruments will be required to be used in specific fields of work, such as the rescue services and casualty wards. In addition, safe instruments are to be used in all activities where bodily fluids can be transferred in quantities which could cause infection. For more details, including the exceptions, see TRBA 250.

Until their publication in the Bundesarbeitsblatt, the new requirements can be viewed here (Section 4.2.4, PDF file: 88 KB) (only available in german) and on the BAuA website (www.baua.de under "Biologische Arbeitsstoffe").
Contact:
KOBAS is supervised and managed by the
BG-Zentrale für Sicherheit und Gesundheit (BGZ) des HVBG
Dr. Stefan Dreller
Tel. +49 (0)2241 2311322 or 2311340
Fax: + 49 (0)2241 2311233


print   print   Submit  submit   Pagefeedback  Pagefeedback   Webcode  Webcode: 2158546